UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of November 2026
Commission
File Number: 001-42418
PMA
Graphene Technology Group Inc.
(Registrant’s
Name)
Office
Unit B8, 27/F
NCB
Innovation Centre
No.
888 Lai Chi Kok Road
Kowloon,
Hong Kong
(Address
of Principal Executive Offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
When
used in this Form 6-K, unless otherwise indicated, the terms “the Company,” “PMA,” “we,”
“us” and “our” refer to PMA Graphene Technology Group Inc.
Stock
Purchase Agreement
On
November 18, 2026, the Company entered into a stock purchase agreement (the “SPA”) to acquire the entire issued share
capital of Lanchuang Technology Limited, a BVI business company incorporated under the laws of the British Virgin Islands (the “Target
Company”), with the shareholders of the Target Company (each a “Seller” and, collectively, the “Sellers”),
and the Target Company. Based on information provided by the Sellers and the Target Company, which the Company has not independently
verified, the Target Company is mainly engaged in the development and provision, through its wholly owned Hong Kong subsidiary, of Internet
of Things (IoT) sensors and monitoring terminals, artificial intelligence (AI) algorithm models and cloud service platform solutions
for ecological, environmental and production safety monitoring, serving government regulatory authorities and industrial enterprises.
The
aggregate consideration of US$260,000,000 is payable in full in securities of the Company, and no cash is payable by the Company at closing.
It comprises (i) US$81,250,000 worth of Class A ordinary shares of the Company, par value US$0.0005 per share (the “Class A
Ordinary Shares”), to be issued at closing at an agreed reference price of US$1.30 per share, for an aggregate amount of 62,500,000
Class A Ordinary Shares (the “Consideration Shares”), and (ii) unsecured convertible promissory notes in the aggregate
original principal amount of US$178,750,000 (the “Notes”), to be issued at closing pursuant to a note purchase agreement
to be entered into at closing (the “NPA”). The consideration (including both the Consideration Shares and the Notes)
is allocated between the Sellers in proportion to their respective interests in the Target Company.
The
Notes and the NPA
The
Notes will be unsecured, will not bear interest and will have no fixed maturity date, and will rank pari passu with the Company’s
other present and future unsecured and unsubordinated obligations. The Notes are convertible into Class A Ordinary Shares at a fixed
conversion price of US$1.30 per share, subject to the conditions summarized below.
The
principal amount of the Notes is divided into three equal annual performance tranches, each corresponding to one of three consecutive
twelve-month performance years commencing on the closing date and covered by the financial forecast provided by the Target Company (the
“Financial Forecast”). A performance tranche becomes eligible for conversion only if the net profit after tax of the
Target Company for the corresponding performance year reaches an agreed minimum threshold by reference to the Financial Forecast, as
determined by the Company, and only after the Company has issued a written conversion eligibility notice in respect of that tranche.
No performance tranche attributable to a later performance year may be accelerated into an earlier performance year. Once a tranche becomes
eligible, its unconverted balance shall remain available for subsequent conversion, subject to the applicable limitations.
Closing
and conditions
Closing
of the transaction is scheduled to occur on December 15, 2026, or such other date as the Company and the Sellers may agree in writing,
subject to the satisfaction or waiver of the conditions set out in the SPA, which include the completion by the Company of due diligence
to its reasonable satisfaction and the submission of the required Listing of Additional Shares notification to The Nasdaq Stock Market
LLC (“Nasdaq”) under Nasdaq Listing Rule 5250(e)(2) without objection from Nasdaq within the applicable notice period.
If closing has not occurred on or before March 31, 2027, either the Company or the Sellers may terminate the SPA in accordance with its
terms. The Company gives no assurance that the transaction will be completed, or that it will be completed within the expected timeframe.
Further
information and securities law matters
As
disclosed in the Company’s annual report on Form 20-F, the Company, as a foreign private issuer, has elected to follow Cayman Islands
home country practice in lieu of certain Nasdaq corporate governance requirements as permitted by Nasdaq Listing Rule 5615(a)(3), including
the shareholder approval requirements of Nasdaq Listing Rules 5635(a), 5635(b) and 5635(d). Accordingly, the Company has not convened
a general meeting of shareholders to approve the transaction.
The
Consideration Shares, the Notes and any Class A Ordinary Shares issuable upon conversion of the Notes have not been, and will not be,
registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and are being issued outside
the United States to persons who are not U.S. persons in offshore transactions in reliance on Regulation S under the Securities Act.
The securities will bear restrictive legends and are subject to transfer restrictions, including a one-year distribution compliance period.
This announcement is for information purposes only and does not constitute an offer to sell, or the solicitation of an offer to buy,
any securities.
The
foregoing descriptions of the SPA, the NPA and the Notes do not purport to be complete and are qualified in their entirety by reference
to the SPA (including the forms of the NPA and the Notes attached thereto), which is filed as Exhibit 10.1 hereto and which is incorporated
herein by reference.
Forward-Looking
Statements
This
Report on Form 6-K and the Press Release contain forward-looking statements within the meaning of Section 27A of the Securities Act and
Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, without limitation, statements regarding
the closing of the SPA and the NPA, the issuance of shares and the Notes, the approval of Nasdaq with respect to the transactions contemplated
by the SPA, the NPA, the issuance of shares and the Notes, the conversion of the Notes, and the expected timeframe of the closing of
the transaction. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance.
Such statements can be identified by the fact that they do not relate strictly to historical or current facts. These statements involve
risks and uncertainties that could cause actual results to differ materially, including risks discussed under the “Risk Factors”
section in the Company’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission. These forward-looking
statements are based on information available as of the date hereof, and expectations, forecasts and assumptions as of that date, and
involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing
our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or
circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required
under applicable securities laws.
Exhibits.
| Exhibit
No. |
|
Description |
| 10.1* |
|
Stock Purchase Agreement by and among the Company, Lanchuang Technology Limited and the Sellers listed on Annex I thereto, dated November 18, 2026 |
*
Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant
agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| |
PMA
Graphene Technology Group Inc. |
| |
|
|
| Date:
November 18, 2026 |
By: |
/s/
LIU Lei |
| |
Name: |
LIU
Lei |
| |
Title: |
Chief
Executive Officer |